Novavax Inc said on Wednesday it has signed an agreement with the Australian government to supply 40 million doses of its COVID-19 vaccine candidate, NVX-CoV2373.

Novavax Inc said on Monday it ended the third quarter with $334.2 million in cash and cash equivalents, as it prepares to start a delayed U.S.-based late-stage trial of its COVID-19 vaccine candidate ...

Americans headed to pharmacies for COVID-19 vaccines are running into roadblocks and confusion due to new U.S. guidance that ...

Americans headed to pharmacies for covid-19 vaccines are running into roadblocks and confusion due to new U.S. guidance that ...

Assignment of the lease for the facility and sale of assets are expected to close in January and result in $40 million in payments to Novavax, while the sale of property adjacent to the headquarters ...

Novavax (NVAX) stock is in focus as the company assign its Gaithersburg facility to AstraZeneca (AZN) in a deal worth nearly ...

Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. | Novavax will remain headquartered at ...

Novavax is shrinking its Montgomery County footprint and turning over much of its space to a pharmaceutical giant that's ...

Novavax transfers EU rights for Nuvaxovid to Sanofi, earning milestone payments and future royalties. Read more here.

Sanofi recently announced an expansion of its licensing agreement with Novavax, granting it broader rights to use Novavax's Matrix-M adjuvant in Sanofi's pandemic influenza vaccine candidate program ...